Amylyx Pharmaceuticals Inc (AMLX) — Defensive Interval Ratio
Amylyx Pharmaceuticals Inc (AMLX) has a Defensive Interval Ratio of 3476 days as of June 2026. Defensive assets of $201.43 Million (cash $-, short-term investments $201.43 Million, receivables $-) cover 3476 days of daily cash needs of $57.95K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Amylyx Pharmaceuticals Inc Defensive Interval Ratio (2020–2025)
This chart shows how Amylyx Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 3476 days, meaning defensive assets of $201.43 Million can fund 3476 days of operations without new revenue. For the complete balance sheet picture, see Amylyx Pharmaceuticals Inc assets under control.
Annual Defensive Interval Ratio for Amylyx Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Amylyx Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Amylyx Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1455 days | $90.42 Million | $62.16K/day | $- | $90.33 Million | ▲ +175 days |
| 2024 | 1279 days | $99.56 Million | $77.82K/day | $- | $99.11 Million | ▲ +206 days |
| 2023 | 1073 days | $241.21 Million | $224.77K/day | $- | $201.16 Million | ▼ -1274 days |
| 2022 | 2347 days | $299.73 Million | $127.70K/day | $- | $284.42 Million | ▲ +1384 days |
| 2021 | 964 days | $45.93 Million | $47.66K/day | $- | $45.93 Million | ▲ +964 days |
| 2020 | 0 days | $0.00 | $20.07K/day | $- | $0.00 | — |